Cargando…

Use of (18)F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer

[Image: see text] We generated (18)F-labeled antibody fragments for positron emission tomography (PET) imaging using a sortase-mediated reaction to install a trans-cyclooctene-functionalized short peptide onto proteins of interest, followed by reaction with a tetrazine-labeled-(18)F-2-deoxyfluoroglu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashidian, Mohammad, Keliher, Edmund J., Dougan, Michael, Juras, Patrick K., Cavallari, Marco, Wojtkiewicz, Gregory R., Jacobsen, Johanne T., Edens, Jerre G., Tas, Jeroen M. J., Victora, Gabriel, Weissleder, Ralph, Ploegh, Hidde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778250/
https://www.ncbi.nlm.nih.gov/pubmed/26955657
http://dx.doi.org/10.1021/acscentsci.5b00121
_version_ 1782419431812497408
author Rashidian, Mohammad
Keliher, Edmund J.
Dougan, Michael
Juras, Patrick K.
Cavallari, Marco
Wojtkiewicz, Gregory R.
Jacobsen, Johanne T.
Edens, Jerre G.
Tas, Jeroen M. J.
Victora, Gabriel
Weissleder, Ralph
Ploegh, Hidde
author_facet Rashidian, Mohammad
Keliher, Edmund J.
Dougan, Michael
Juras, Patrick K.
Cavallari, Marco
Wojtkiewicz, Gregory R.
Jacobsen, Johanne T.
Edens, Jerre G.
Tas, Jeroen M. J.
Victora, Gabriel
Weissleder, Ralph
Ploegh, Hidde
author_sort Rashidian, Mohammad
collection PubMed
description [Image: see text] We generated (18)F-labeled antibody fragments for positron emission tomography (PET) imaging using a sortase-mediated reaction to install a trans-cyclooctene-functionalized short peptide onto proteins of interest, followed by reaction with a tetrazine-labeled-(18)F-2-deoxyfluoroglucose (FDG). The method is rapid, robust, and site-specific (radiochemical yields > 25%, not decay corrected). The availability of (18)F-2-deoxyfluoroglucose avoids the need for more complicated chemistries used to generate carbon–fluorine bonds. We demonstrate the utility of the method by detecting heterotopic pancreatic tumors in mice by PET, using anti-Class II MHC single domain antibodies. We correlate macroscopic PET images with microscopic two-photon visualization of the tumor. Our approach provides easy access to (18)F-labeled antibodies and their fragments at a level of molecular specificity that complements conventional (18)F-FDG imaging.
format Online
Article
Text
id pubmed-4778250
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-47782502016-05-09 Use of (18)F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer Rashidian, Mohammad Keliher, Edmund J. Dougan, Michael Juras, Patrick K. Cavallari, Marco Wojtkiewicz, Gregory R. Jacobsen, Johanne T. Edens, Jerre G. Tas, Jeroen M. J. Victora, Gabriel Weissleder, Ralph Ploegh, Hidde ACS Cent Sci [Image: see text] We generated (18)F-labeled antibody fragments for positron emission tomography (PET) imaging using a sortase-mediated reaction to install a trans-cyclooctene-functionalized short peptide onto proteins of interest, followed by reaction with a tetrazine-labeled-(18)F-2-deoxyfluoroglucose (FDG). The method is rapid, robust, and site-specific (radiochemical yields > 25%, not decay corrected). The availability of (18)F-2-deoxyfluoroglucose avoids the need for more complicated chemistries used to generate carbon–fluorine bonds. We demonstrate the utility of the method by detecting heterotopic pancreatic tumors in mice by PET, using anti-Class II MHC single domain antibodies. We correlate macroscopic PET images with microscopic two-photon visualization of the tumor. Our approach provides easy access to (18)F-labeled antibodies and their fragments at a level of molecular specificity that complements conventional (18)F-FDG imaging. American Chemical Society 2015-06-03 2015-06-24 /pmc/articles/PMC4778250/ /pubmed/26955657 http://dx.doi.org/10.1021/acscentsci.5b00121 Text en Copyright © 2015 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Rashidian, Mohammad
Keliher, Edmund J.
Dougan, Michael
Juras, Patrick K.
Cavallari, Marco
Wojtkiewicz, Gregory R.
Jacobsen, Johanne T.
Edens, Jerre G.
Tas, Jeroen M. J.
Victora, Gabriel
Weissleder, Ralph
Ploegh, Hidde
Use of (18)F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer
title Use of (18)F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer
title_full Use of (18)F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer
title_fullStr Use of (18)F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer
title_full_unstemmed Use of (18)F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer
title_short Use of (18)F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer
title_sort use of (18)f-2-fluorodeoxyglucose to label antibody fragments for immuno-positron emission tomography of pancreatic cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778250/
https://www.ncbi.nlm.nih.gov/pubmed/26955657
http://dx.doi.org/10.1021/acscentsci.5b00121
work_keys_str_mv AT rashidianmohammad useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer
AT keliheredmundj useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer
AT douganmichael useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer
AT juraspatrickk useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer
AT cavallarimarco useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer
AT wojtkiewiczgregoryr useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer
AT jacobsenjohannet useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer
AT edensjerreg useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer
AT tasjeroenmj useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer
AT victoragabriel useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer
AT weisslederralph useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer
AT ploeghhidde useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer